期刊文献+

胰腺癌细胞中蛋白磷酸酶2A催化性C亚基低表达对癌细胞生长的影响 被引量:2

Down-regulated expression of PP2A catalytic subunit in pancreatic cancer cells promotes cell growth
原文传递
导出
摘要 目的探讨蛋白磷酸酶2A催化性C亚基(PP2Ac)在胰腺癌组织和细胞系中的表达水平,及其对JNK/c-Jun/AP-1信号通路的调控作用和对癌细胞生长的影响。方法采用实时PCR检测PP2Ac表达水平,MTF法检测细胞活力,Western印迹检测蛋白表达水平和磷酸化水平,流式细胞术检测细胞周期,荧光素酶报告基因检测转录活性。结果胰腺癌组织中PP2Ac表达水平显著低于癌旁组织,胰腺癌细胞系中PP2Ac也呈低水平表达,在胰腺癌细胞中过表达PP2Ac可抑制癌细胞生长(转染PP2Acct、PP2Acl348h后可使细胞活力分别下降(24.85±4.85)%、(11.31±4.62)%;72h后细胞活力分别下降(33.89±2.05)%、(16.66±2.81)%;PP2Ac低水平表达可上调JNK/c.Jun/AP-1通路的活性,在胰腺癌细胞中过表达PP2Ac可下调JNK、C-Jun的磷酸化水平并抑制AP-1的转录沿眭;采用抑制剂阻断JNK通路,可阻滞细胞周期于G2/M期,进而抑制细胞生长。结论胰腺癌细胞中PP2Ac呈低表达,通过上调JNK/c-Jun/AP-1通路的活性促进胰腺癌细胞生长。 Objective To investigate the expression of protein phosphatase 2A catalytic subunit (PP2Ac) in pancreatic cancer and the regulation of this gene on JNK/c-Jun/AP-1 pathway and cell growth. Methods Expression of PP2Ac was determined by real-time PCR. Cell viability was tested by MTT. Expression and phosphorylation levels of proteins were detected by Western blotting. Cell cycle was assayed by flow cytometry. Transcription activity was measured by luciferase reporter gene assay. Results Suppressed PP2Ac expression was detected in pancreatic cancer tissues. PP2Ac expression in the pancreatic cancer cell lines was also at a low level. Overexpression of the two isoforms of PP2Ac,PP2Acct and PP2Aα, in. pancreatic cancer cells repressed cell growth. Cell viability decreased (33.89 ± 2. 05 ) % ( t = 28. 607, P〈0.001) and (16.66 ±2. 81)% (t = 10.257, P = 0.001) respectively 72 hours after transfection. Overexpression of PP2Acα and PP2Acl3 down-regulated the phosphorylation levels of JNK and c- Jun,and made the transcriptional activity of AP-1 decrease (47. 18 +2. 28) % (t = 11. 230,P 〈0. 001 ) and (30. 89 ± 8.09 ) % ( t = 6. 612, P = 0. 003 ) respectively, indicating the down-regulation of PP2Ac up- regulated the activity of JNK/c-Jun/AP-1 pathway. Blocking the JNK pathway using a selective inhibitor, SP600125, induced G2/M cell cycle arrest and repressed cell proliferation. Cell viability decreased (31.38± 1.33) % ( t = 40. 930,P 〈 0. 001 ) after treatment with JNK inhibitor for 72 hours. Conclusion Suppressed expression of PP2Ac in pancreatic cancer facilitated cell growth through up-regulating the activity of JNK/c- Jun/AP-1 pathway.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第2期86-89,共4页 National Medical Journal of China
基金 国家自然科学基金(81072031、81101867、81272542、81200369) 江苏省自然科学基金(BK2010585) 江苏省中医药局科技项目(1213236) 苏州市科教兴卫青年科技项目(SWKQ1003、SWKQ1011)
关键词 蛋白质磷酸酶2 胰腺肿瘤 JNK信号通路 c—Jun AP-1 Protein phosphatase 2 Pancreatic neoplasms JNK c-Jun AP-1
  • 相关文献

参考文献12

  • 1Neoptolemos JP,Dunn JA,Stocken DD. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:a randomised controlled trial[J].{H}LANCET,2001.1576-1585.
  • 2Bose C,Udupa KB. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals[J].{H}American Journal of Physiology Cell Physiology,2008.C394-C405.
  • 3Li M,Feurino LW,Li F. Thymosinalphal stimulates cell proliferation by activating ERK1/2,JNK,and increasing cytokine secretion in human pancreatic cancer cells[J].{H}CANCER LETTERS,2007.58-67.
  • 4Xiong HQ. Molecular targeting therapy for pancreatic cancer[J].{H}Cancer Chemotherapy and Pharmacology,2004,(Suppl 1):S69-S77.
  • 5Westermarck J,Hahn WC. Multiple pathways regulated by the tumor suppressor PP2A in transformation[J].{H}Trends in Molecular Medicine,2008.152-160.
  • 6Millward TA,Zolnierowicz S,Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A[J].{H}Trends in Biochemical Sciences,1999.186-191.
  • 7Janssens V,Goris J,Van Hoof C. PP2A:the expected tumor suppressor[J].{H}Current Opinion in Genetics & Development,2005.34-41.
  • 8Yin Y,Wang S,Sun Y. JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells[J].{H}Biomedicine and Pharmacotherapy,2009.429-435.
  • 9Weston CR,Davis RJ. The JNK signal transduction pathway[J].{H}Current Opinion in Cell Biology,2007.142-149.
  • 10张真发,马建群,张林.有丝分裂激活的蛋白激酶家族基因在非小细胞肺癌中的表达及临床意义[J].中华医学杂志,2005,85(5):339-342. 被引量:4

二级参考文献19

  • 1李大卫,吴晴,彭志海,杨兆瑞,胡宏慧,王一,李倩玉.缺氧诱导因子-1α和P糖蛋白、多药耐药相关蛋白1、肺耐药相关蛋白在胃癌中的表达及意义[J].中华实验外科杂志,2007,24(5):537-539. 被引量:10
  • 2Mansouri A, Ridgway LD, Korapati AL, et al. Sustained activation of JNK/P38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem, 2003,278 : 19245-19256.
  • 3Zhou J, Liu M, Aneja R, et al. Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res,2006 ;66:445-452.
  • 4Heasley LE,Han SY. JNK regulation of oncogenesis. Mol Cells,2006, 21 : 167-173.
  • 5Seger R, Krebs EG. The MAPK signaling cascade. FASEB J, 1995, 9:726-735.
  • 6Widmann, Christian, Spencer G, et al. Mitogen-activated protein kinase: conservation of a three-kinase module fromyeast to human. Physiol Rev, 1999,79:143-180.
  • 7Hobson SA, Wright J, Lee F, et al. Activation of the MAP kinase cascade by exogenous calcium-sensing receptor. Mol Cell Endocrinol, 2003, 200(1-2): 189-198.
  • 8Johnson GL, Lapadat R. Mitogen activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002,298:1911-1912.
  • 9Peyssonnaux C, Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell,2001, 93:53-62.
  • 10Weston CR, Lambright DG, Davis RJ. Signal transduction. MAP kinase signaling specificity. Science, 2002, 296:2345-2347.

共引文献7

同被引文献17

  • 1Gui-QinBai,YanLiu,JunCheng,Shu-LinZhang,Ya-FeiYue,Yan-PingHuang,Li-YingZhang.Transactivating effect of complete S protein of hepatitis B virus and cloning of genes transactivated by complete S protein using suppression subtractive hybridization technique[J].World Journal of Gastroenterology,2005,11(25):3893-3898. 被引量:6
  • 2Popescu I, Dumitrascu T. Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma [J]. Hepatogastroenterol, 2011 ,58 : 202-207.
  • 3Heald RJ, Husband EM, Ryall RD, et al. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? [J]. Br J Surg, 1982,69 :613-616.
  • 4Hohenberger W , Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome [J] . Coloreetal Dis, 2009, 11 : 354- 365.
  • 5Gaedcke J, Gunawan B, Grade M, et aL The mesopancreas is the primary site for Rl resection in pancreatic head cancer: relevance for clinical trials [J] . Langenbecks Arch Surg, 2010,395: 451- 458.
  • 6Gockel I, Domeyer M, Wolloscheck T, et al. Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space[J]. World J Surg Oncol,2007,5 :44.
  • 7Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? [J]. Ann Surg,2008 ,247 :456462.
  • 8Adham M, Singhirunnusom J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors [J] . Eur J Surg Oncol ,2012 ,38 :340-345.
  • 9Kawabata Y, Tanaka T, Nishi T, et aL Appraisal of a total meso?pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma [J]. Eur J Surg Oncol, 2012,38: 574- 579.
  • 10Agrawal MK, Thakur OS, Somashekar U, et al. Mesopancreas , myth or reality? [J]. JOP ,2010,11 :230-233.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部